Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HKSE:02159's EV-to-FCF is ranked worse than 92.35% of 405
companies
in the Healthcare Providers & Services industry
Industry Median: 18.42
vs HKSE:02159: 129.03
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Mediwelcome Healthcare Management & Technology's PE Ratio (TTM) for today is calculated as:
Mediwelcome Healthcare Management & Technology's share price for today is HK$1.78.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Mediwelcome Healthcare Management & Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.175.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Mediwelcome Healthcare Management & Technology EV-to-FCF Related Terms
Mediwelcome Healthcare Management & Technology EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02159 vs VEEV, BTSG, HQY: EV-to-FCF Comparison
For the Health Information Services subindustry, Mediwelcome Healthcare Management & Technology's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mediwelcome Healthcare Management & Technology EV-to-FCF vs Healthcare Providers & Services Industry
Mediwelcome Healthcare Management & Technology's current Enterprise Value is HK$461.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Mediwelcome Healthcare Management & Technology's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$3.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mediwelcome Healthcare Management & Technology (HKSE:02159) has a EV-to-FCF of 129.03 as of Aug. 08, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Mediwelcome Healthcare Management & Technology and its competitors. According to the industry distribution chart, Mediwelcome Healthcare Management & Technology ranks #374 out of 405 companies in the Healthcare Providers & Services industry, placing it in the top 92.3%.
Is Mediwelcome Healthcare Management & Technology's EV-to-FCF too high?
Mediwelcome Healthcare Management & Technology's current EV-to-FCF is 129.03. The Healthcare Providers & Services industry median EV-to-FCF is 18.42. Mediwelcome Healthcare Management & Technology's value of 129.03 is 600.5% above this industry median. Based on the distribution chart, Mediwelcome Healthcare Management & Technology ranks #374 out of 405 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Mediwelcome Healthcare Management & Technology has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mediwelcome Healthcare Management & Technology's EV-to-FCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Mediwelcome Healthcare Management & Technology ranks #374 out of 405 companies for EV-to-FCF. This places Mediwelcome Healthcare Management & Technology in the lower half of its industry. The industry median EV-to-FCF is 18.42. Mediwelcome Healthcare Management & Technology's value of 129.03 is 600.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.42, based on 405 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mediwelcome Healthcare Management & Technology's current EV-to-FCF of 129.03 is 600.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Mediwelcome Healthcare Management & Technology and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mediwelcome Healthcare Management & Technology's current EV-to-FCF is 129.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mediwelcome Healthcare Management & Technology stock overvalued right now?
Based on GuruFocus' analysis, Mediwelcome Healthcare Management & Technology (HKSE:02159) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.70, compared to a current price of HK$1.78 — trading 154.3% above its estimated fair value. The current EV-to-FCF is 129.03 and 600.5% above the Healthcare Providers & Services industry median of 18.42. Mediwelcome Healthcare Management & Technology's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Mediwelcome Healthcare Management & Technology (HKSE:02159), the current EV-to-FCF is 129.03 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mediwelcome Healthcare Management & Technology (HKSE:02159) Overvalued in 2026?
Based on GuruFocus' analysis, Mediwelcome Healthcare Management & Technology stock appears to be overvalued.
The current stock price of HK$1.78 is trading 154.3% above its estimated GF Value™ of HK$0.70.
GuruFocus considers Mediwelcome Healthcare Management & Technology to be Significantly Overvalued.
Key valuation signals for HKSE:02159:
EV-to-FCF: 129.03
GF Value™: HK$0.70 vs. price of HK$1.78 (154.3% above fair value)
Industry Position: 600.5% above the Healthcare Providers & Services median (#374 of 405)
No single metric tells the full story. See the HKSE:02159 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mediwelcome Healthcare Management & Technology Inc is an investment holding company. The Group mainly provides medical conference services, patient education and screening services, and marketing and consulting services, in addition to providing integrated healthcare marketing solutions. Its products and services include Academic Conference Management System, Scientific Research Data Reporting System, the Health/Medical Media Matrix, patient management services, and marketing and consulting services. The Group has only one reportable segment, mainly operating its businesses in the PRC and earning revenue from the PRC.
54GF Score
Get the complete analysis for HKSE:02159
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02159 has been successfully added to your 
